Table 3 Baseline characteristics, disease activity, and quality of care received stratified by complete and incomplete baseline DAS28 data
From: Data quality predicts care quality: findings from a national clinical audit
Complete baseline DAS28 data | Incomplete baseline DAS28 data | p values | |
|---|---|---|---|
(N = 4075) | (N = 2130) | ||
Age, mean (SD) | 59.0 (14.8) | 56.6 (15.8) | < 0.0001 |
Female | 64.1% | 62.8% | 0.3 |
IMD rank, median (Q1, Q3) | 638 (306, 1021) | 639 (270, 1021) | 0.3 |
White European | 90.6% | 91.3% | 0.5 |
Current Smoker | 23.5% | 19.8% | 0.003 |
Full time paid employment | 36.8% | 40.7% | 0.008 |
Seropositive | 83.0% | 65.3% | < 0.0001 |
DAS28 at follow-up, mean (SD) | 3.5 (1.5) | 3.6 (1.5) | 0.3 |
Symptom duration in days, median (Q1, Q3) | 98 (52, 208) | 114 (56, 256) | 0.0001 |
Referral letter states EIA | 91.2% | 88.8% | 0.002 |
Referral within 3 days | 16.5% | 18.0% | 0.1 |
Review within 21 days | 36.9% | 36.7% | 0.6 |
Treatment within 90 days | 65.3% | 50.3% | < 0.0001 |